Related Experiment Video
Updated: Jul 14, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Systemic lupus erythematosus-like disease in a 6-year-old boy with prolidase deficiency
M Di Rocco1, A R Fantasia, M Taro
12nd Division of Pediatrics, University of Genoa, G. Gaslini Institute, Largo Gaslini 5, 16147, Genoa, Italy. majadirocco@ospedale-gaslini.ge.it
Insights
Prolidase deficiency can mimic systemic lupus erythematosus, presenting with similar immunological features and skin lesions. Early diagnosis of this metabolic disorder is crucial for appropriate management.
Area of Science:
- Immunology
- Metabolic Disorders
- Dermatology
Background:
- Prolidase deficiency is a rare inherited metabolic disorder.
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
- Both conditions can present with complex immunological and clinical manifestations.
Observation:
- A pediatric case presented with splenomegaly, leg ulcers, and significant immunological abnormalities including hypergammaglobulinaemia and autoantibodies.
- Initial diagnosis of SLE was considered due to vasculitic skin lesions and positive autoantibodies, but diagnostic criteria were not fully met.
- Immunosuppressive therapy for suspected SLE worsened the skin lesions.
Findings:
- The patient was ultimately diagnosed with prolidase deficiency, a metabolic disorder.
- Prolidase deficiency shares immunological similarities with SLE, including autoantibody production and complement consumption.
- The metabolic defect in prolidase deficiency may contribute to immune dysregulation through altered apoptosis processing.
Implications:
- This case highlights the importance of considering metabolic disorders in the differential diagnosis of autoimmune diseases.
- Understanding the link between prolidase deficiency and immune dysfunction may reveal new pathogenetic pathways for autoimmune conditions.
- Further research into the role of apoptosis and immune clearance mechanisms in prolidase deficiency is warranted.
Abstract:
This report describes the case of a boy with prolidase deficiency who presented with splenomegaly and leg ulcers. Laboratory examination revealed hypergammaglobulinaemia, hyperimmunoglobulinaemia E, increased erythrocyte sedimentation rate, elevated transaminases, positive antinuclear and anti-double-stranded DNA antibodies, and complement consumption. No haematological, renal or articular problems were detected; neutrophil count was normal. The skin lesions were thought to be of vasculitic origin, and a diagnosis of systemic lupus erythematosus was made although the requirements for diagnosis of systemic lupus erythematosus based on American Rheumatism Association criteria were not satisfied. The child was treated with immunosuppressive drugs with worsening of skin lesions before the diagnosis of prolidase deficiency. Prolidase deficiency and systemic lupus erythematosus share a number of common immunological features and at least three patients with prolidase deficiency and immunological and clinical findings fulfilling the diagnostic criteria for systemic lupus erythematosus of the American Rheumatism Association are reported in the literature. Here we review pathogenetic hypothesis linking the metabolic defect to the disturbance in immune function. In particular we discuss the role of highly increased rates of apoptosis and/or abnormal processing of apoptotic keratinocytes in prolidase deficiency and the role of C1q deficiency, which is associated with the failure of normal clearance of apoptotic cells bearing on their surfaces many of the autoantigens involved in systemic lupus erythematosus.
Related Concept Videos
Lysosomal Hydrolases
Inborn Errors of Metabolism
Pedigree Analysis
Pleiotropy
